Log in to save to my catalogue

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone...

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87f7e92b53fe4921b5c3c705d6878603

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

About this item

Full title

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Clinical ophthalmology (Auckland, N.Z.), 2013-01, Vol.7 (default), p.1565-1570

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

To identify baseline characteristics that predict the number of treatments with intravitreal triamcinolone acetonide (IVTA) plus laser photocoagulation needed to treat diabetic macular edema over a 2-year period.
Individual data from 42 eyes of 42 participants treated with IVTA plus laser photocoagulation for diabetic macular edema during a pros...

Alternative Titles

Full title

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_87f7e92b53fe4921b5c3c705d6878603

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87f7e92b53fe4921b5c3c705d6878603

Other Identifiers

ISSN

1177-5467,1177-5483

E-ISSN

1177-5483

DOI

10.2147/OPTH.S47424

How to access this item